Inhibition of phosphatidylinositol 3-kinase causes cell death in rat osteoblasts through inactivation of Akt

Biomedicine and Pharmacotherapy

Volumn 61, Issue 5, 2007, Pages 277-284

  Zhang, Yun ^a   Zhang, Le ^a   Yan, Ming ^a   Zheng, Xiaoxiang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

LY294002; Osteoblasts; PI3 kinase Akt pathway

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; IMMUNOCYTOCHEMISTRY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CHROMONES; CYTOPLASM; IMMUNOHISTOCHEMISTRY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MORPHOLINES; OSTEOBLASTS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

EID: 34249986378     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.02.014     Document Type: Article

References (31)

1. Vivanco I., and Sawyers C.L. The phsophatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer 2 (2002) 489-501
2. Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., et al. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9 8 (1999) 393-404
3. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 (2000) 561-576
4. Luo H.R., Hattori H., Hossain M.A., Hester L., Huang Y.F., Lee-Kwon W., et al. Akt as a mediator of cell death. PNAS USA 100 (2003) 11712-11717
5. Romashkova J.A., and Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401 (1999) 86-90
6. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96 (1999) 857-868
7. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couple survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
8. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
9. Krasilnikov M.A. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 65 (2000) 59-67
10. Lee S.B., Hong S.H., Kim H., and Um H.D. Co-induction of cell death and survival pathways by phosphoinositide 3-kinase. Life Sci 78 1 (2005) 91-98
11. Gottschalk A.R., Doan A., Nakamura J.L., Hass-Kogan D.A., and Stokoe D. Inhibition of phosphatidylinositol-3 kinases on cell death through a protein kinase B (PKB)-dependent mechanism and growth arrest through a PKB-independent mechanism. Int J Radiat Oncol Biol Phys 61 4 (2005) 1183-1188
12. Borgatti P., Martelli A.M., Bellacosa A., Casto R., Massari L., Capitani S., et al. Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 477 (2000) 27-32
13. Danciu T.E., Adam R.M., Naruse K., Freeman M.R., and Hauschka P.V. Calcium regulates the PI3K-Akt pathway in stretched osteoblasts. FEBS Lett 536 (2003) 193-197
14. Kang H.Y., Cho C.L., Huang K.L., Wang J.C., Hu Y.C., Lin H.K., et al. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J Bone Miner Res 19 (2004) 1181-1190
15. Noda T., Tokuda H., Yoshida M., Yasuda E., Hanai Y., Takai S., et al. Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts. Horm Metab Res 37 (2005) 270-274
16. Atencia R., Asumendi A., and Garcia-Sanz M. Role of cytoskeleton in apoptosis. Vitam Horm 58 (2000) 267-297
17. Bursch W., Hochegger K., Torok L., Marian B., Ellinger A., and Hermann R.S. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 113 7 (2000) 1189-1198
18. Grzanka A., Grzanka D., and Orlikowska M. Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem Pharmacol 66 8 (2003) 1611-1617
19. Brown S.B., Bailey K., and Savill J. Actin is cleaved during constitutive apoptosis. J Biochem 323 (1997) 233-237
20. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269 (1994) 5241-5248
21. Gu Q., Zhu H.M., and Zhang X.J. Apoptosis of rat osteoblasts in process of calcification in vitro. Acta Pharmacol Sin 23 9 (2002) 808-812
22. Ceneviva G.D., Tzeng E., Hoyt D.G., Yee E., Gallagher A., Engelhardt J.F., et al. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 275 (1998) L717-L728
23. Harada-Shiba M., Kinoshita M., Kamido H., and Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem 273 (1998) 9681-9687
24. Agrawala P.K., Mittal A., Bala M., and Goel H.C. Mitochondrial involvement in RP-1 mediated apoptosis in U87 cells. Biomed Pharmacother 58 (2004) 129-135
25. Uddin S., Hussain A., Al-Hussein K., Platanias L.C., and Bhatia K.G. Inhibition of phosphatidylinositol 3-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. Biochem Biophys Res Commun 320 (2004) 932-938
26. Nicholson K.M., Quinn D.M., Kellett G.L., and Warr J.R. LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells. Cancer Lett 190 1 (2003) 31-36
27. Yip-Schneider M.T., Wiesenauer C.A., and Schmidt C.M. Inhibition of the phosphatidylinositol 3′-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac. J Gastrointest Surg 7 3 (2003) 354-363
28. Kroemer G., Petit P., ZamZami N., Vayssiere J.L., and Mignotte B. The biochemistry of programmed cell death. FASEB 9 (1995) 1277-1287
29. Martelli A.M., Borgatti P., Bortul R., Marmiroli L., Capitani S., and Neri L.M. Phosphatidylinositol 3-kinase translocation to the nucleus of osteoblast-like MC3T3-E1cells in response to insulin-like growth factor 1 and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor. J Bone Miner Res 15 (2000) 1716-1730
30. Neri L.M., Borgatti P., Capitani S., and Martelli A.M. The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 1584 (2002) 73-80
31. Fujita H., Utsumi T., Muranaka S., Ogino T., Yano H., Akiyama J., et al. Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B. Biochem Pharmacol 69 12 (2005) 1773-1784